STOCK TITAN

REGEN BIOPHARMA PFD A (RGBPP) Net Income by Year

RGBPP

REGEN BIOPHARMA PFD A reported a net loss of $1.3M in fiscal year 2025. This represents a decrease of 90.7% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a $1.2M net loss. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters REGEN BIOPHARMA PFD A has filed alongside them.

FY2025 annual
Net Income -$1.3M
YoY -90.7%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RGBPP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Net Income-$1.2M-$1.3M-90.7%-$668K-157.8%$1.2M-52.7%$2.4MN/AN/AN/AN/AN/AN/AN/AN/A-$355K

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

RGBPP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Net Income-$638K-281.2%$992K+5225.2%-$968K-87.8%-$572K-116.1%-$167K-28.6%-$19K+84.2%-$515K-255.6%-$265K+18.5%-$130K-31.1%-$122K-122.7%-$145K-108.9%-$325K-316.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More REGEN BIOPHARMA PFD A financials

Frequently Asked Questions

What was REGEN BIOPHARMA PFD A's net income in fiscal year 2025?

REGEN BIOPHARMA PFD A reported a net loss of $1.3M in fiscal year 2025.

How fast is REGEN BIOPHARMA PFD A's net income growing?

REGEN BIOPHARMA PFD A (RGBPP) net income fell by 90.7% year over year, from -$668K to -$1.3M in fiscal year 2025.

What is REGEN BIOPHARMA PFD A's net income over the last twelve months?

REGEN BIOPHARMA PFD A (RGBPP) reported a $1.2M net loss over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 13 fiscal years this page covers, REGEN BIOPHARMA PFD A (RGBPP) net income went from -$355K in fiscal year 2013 to -$1.3M in fiscal year 2025.

REGEN BIOPHARMA PFD A (RGBPP) reported -$638K in net income in Q3 2026. This represents a decrease of 281.2% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what REGEN BIOPHARMA PFD A (RGBPP) reported on that line in every period on record.